Skip to main content

Drug Safety

Ausgabe 4/2012

Inhalt (8 Artikel)

Editorial

Clinical Diagnosis

I. Ralph Edwards

Current Opinion

Embedding ‘Speaking Up’ into Systems for Safe Healthcare Product Development and Marketing Surveillance

Brian Edwards, Bruce Hugman, Mary Tobin, Matthew Whalen

Review Article

Safety of Flecainide

Juan Tamargo, Alessandro Capucci, Philippe Mabo

Short Communication

Deriving Dose Limits for Warnings in Electronic Prescribing Systems

Jamie J. Coleman, James Hodson, Robin E. Ferner

Original Research Articles

Risk Minimization Activities of Centrally Authorized Products in the EU

Inge M. Zomerdijk, Fakhredin A. Sayed-Tabatabaei, Gianluca Trifirò, Stella C. F. Blackburn, Miriam C. J. M. Sturkenboom, Sabine M. J. M. Straus

Original Research Articles

Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones

Domenico Motola, Carlo Piccinni, Chiara Biagi, Emanuel Raschi, Anna Marra, Giulio Marchesini, Elisabetta Poluzzi

Original Research Articles

Assessing Opioid Shopping Behaviour

M. Soledad Cepeda, Daniel Fife, Wing Chow, Gregory Mastrogiovanni, Scott C. Henderson

Original Research Articles

Vaccine-Based Subgroup Analysis in VigiBase

Sandra de Bie, Katia M. C. Verhamme, Sabine M. J. M. Straus, Bruno H. Ch. Stricker, Miriam C. J. M. Sturkenboom